Selected research
Industry Growth & Trends
Global Autologous Immune Cell Storage Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Autologous Immune Cell Storage market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Autologous Immune Cell Storage market include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Autologous Immune Cell Storage market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Autologous Immune Cell Storage market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autologous Immune Cell Storage market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autologous Immune Cell Storage.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Autologous Immune Cell Storage market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Autologous Immune Cell Storage Market by Company
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
VCANBIO Cell and Gene Engineering Corp., Ltd.
Shenzhen Beike Bio-Technology Co.,Ltd
Beijing Health and Biotech Group Corp. Ltd.
Shanghai Cell Therapy Group Co. Ltd.
BGI Genomics
Shanghai Saiyao Biotechnology Co., Ltd.
Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Autologous Immune Cell Storage Segment by Type
Lymphocyte Storage
Hematopoietic Stem Cell Storage
Autologous Immune Cell Storage Segment by Application
Treat Leukemia and Blood-Related Diseases
Immune System Modulation
Stem Cell Transplant
Autologous Immune Cell Storage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autologous Immune Cell Storage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autologous Immune Cell Storage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autologous Immune Cell Storage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Autologous Immune Cell Storage companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Lymphocyte Storage
- Hematopoietic Stem Cell Storage
Applications
- Treat Leukemia and Blood-Related Diseases
- Immune System Modulation
- Stem Cell Transplant
Companies covered
- HealthBanks
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
- STEMCELL
- Enhance Biomedical
- Immunaeon
- Miracell
- VCANBIO Cell and Gene Engineering Corp., Ltd.
- Shenzhen Beike Bio-Technology Co.,Ltd
- Beijing Health and Biotech Group Corp. Ltd.
- Shanghai Cell Therapy Group Co. Ltd.
- BGI Genomics
- Shanghai Saiyao Biotechnology Co., Ltd.
- Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Autologous Immune Cell Storage Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Autologous Immune Cell Storage Market Size by Region (2021-2032)
- 1.4.1 Global Autologous Immune Cell Storage Market Size by Region (2021-2026)
- 1.4.2 Global Autologous Immune Cell Storage Market Size by Region (2027-2032)
- 1.5 Key Regions Autologous Immune Cell Storage Market Size (2021-2032)
- 1.5.1 North America Autologous Immune Cell Storage Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Autologous Immune Cell Storage Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Autologous Immune Cell Storage Market Size Growth Rate (2021-2032)
- 1.5.4 South America Autologous Immune Cell Storage Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Autologous Immune Cell Storage Market Size Growth Rate (2021-2032)
2 Autologous Immune Cell Storage Market by Type
- 2.1 Type Introduction
- 2.1.1 Lymphocyte Storage
- 2.1.2 Hematopoietic Stem Cell Storage
- 2.2 Global Autologous Immune Cell Storage Market Size by Type
- 2.2.1 Global Autologous Immune Cell Storage Market Size Overview by Type (2021-2032)
- 2.2.2 Global Autologous Immune Cell Storage Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Autologous Immune Cell Storage Market Size Forecasted by Type (2027-2032)
- 2.3 Global Autologous Immune Cell Storage Market Size by Regions
- 2.3.1 North America Autologous Immune Cell Storage Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Autologous Immune Cell Storage Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Autologous Immune Cell Storage Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Autologous Immune Cell Storage Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Autologous Immune Cell Storage Market Size Breakdown by Type (2021-2026)
3 Autologous Immune Cell Storage Market by Application
- 3.1 Type Introduction
- 3.1.1 Treat Leukemia and Blood-Related Diseases
- 3.1.2 Immune System Modulation
- 3.1.3 Stem Cell Transplant
- 3.2 Global Autologous Immune Cell Storage Market Size by Application
- 3.2.1 Global Autologous Immune Cell Storage Market Size Overview by Application (2021-2032)
- 3.2.2 Global Autologous Immune Cell Storage Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Autologous Immune Cell Storage Market Size Forecasted by Application (2027-2032)
- 3.3 Global Autologous Immune Cell Storage Market Size by Regions
- 3.3.1 North America Autologous Immune Cell Storage Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Autologous Immune Cell Storage Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Autologous Immune Cell Storage Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Autologous Immune Cell Storage Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Autologous Immune Cell Storage Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Autologous Immune Cell Storage Industry Trends
- 4.2 Autologous Immune Cell Storage Industry Drivers
- 4.3 Autologous Immune Cell Storage Industry Opportunities and Challenges
- 4.4 Autologous Immune Cell Storage Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Autologous Immune Cell Storage Revenue (2021-2026)
- 5.2 Global Autologous Immune Cell Storage Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Autologous Immune Cell Storage Key Company Headquarters & Area Served
- 5.4 Global Autologous Immune Cell Storage Company, Product Type & Application
- 5.5 Global Autologous Immune Cell Storage Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Autologous Immune Cell Storage Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Autologous Immune Cell Storage Players Market Share by Revenue in 2025
- 5.6.3 2025 Autologous Immune Cell Storage Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 HealthBanks
- 6.1.1 HealthBanks Company Information
- 6.1.2 HealthBanks Business Overview
- 6.1.3 HealthBanks Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 HealthBanks Autologous Immune Cell Storage Product Portfolio
- 6.1.5 HealthBanks Recent Developments
- 6.2 Aeterna Health
- 6.2.1 Aeterna Health Company Information
- 6.2.2 Aeterna Health Business Overview
- 6.2.3 Aeterna Health Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Aeterna Health Autologous Immune Cell Storage Product Portfolio
- 6.2.5 Aeterna Health Recent Developments
- 6.3 Cell Vault
- 6.3.1 Cell Vault Company Information
- 6.3.2 Cell Vault Business Overview
- 6.3.3 Cell Vault Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cell Vault Autologous Immune Cell Storage Product Portfolio
- 6.3.5 Cell Vault Recent Developments
- 6.4 Redermis
- 6.4.1 Redermis Company Information
- 6.4.2 Redermis Business Overview
- 6.4.3 Redermis Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Redermis Autologous Immune Cell Storage Product Portfolio
- 6.4.5 Redermis Recent Developments
- 6.5 Innovita Research
- 6.5.1 Innovita Research Company Information
- 6.5.2 Innovita Research Business Overview
- 6.5.3 Innovita Research Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Innovita Research Autologous Immune Cell Storage Product Portfolio
- 6.5.5 Innovita Research Recent Developments
- 6.6 STEMCELL
- 6.6.1 STEMCELL Company Information
- 6.6.2 STEMCELL Business Overview
- 6.6.3 STEMCELL Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 STEMCELL Autologous Immune Cell Storage Product Portfolio
- 6.6.5 STEMCELL Recent Developments
- 6.7 Enhance Biomedical
- 6.7.1 Enhance Biomedical Company Information
- 6.7.2 Enhance Biomedical Business Overview
- 6.7.3 Enhance Biomedical Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Enhance Biomedical Autologous Immune Cell Storage Product Portfolio
- 6.7.5 Enhance Biomedical Recent Developments
- 6.8 Immunaeon
- 6.8.1 Immunaeon Company Information
- 6.8.2 Immunaeon Business Overview
- 6.8.3 Immunaeon Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Immunaeon Autologous Immune Cell Storage Product Portfolio
- 6.8.5 Immunaeon Recent Developments
- 6.9 Miracell
- 6.9.1 Miracell Company Information
- 6.9.2 Miracell Business Overview
- 6.9.3 Miracell Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Miracell Autologous Immune Cell Storage Product Portfolio
- 6.9.5 Miracell Recent Developments
- 6.10 VCANBIO Cell and Gene Engineering Corp., Ltd.
- 6.10.1 VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information
- 6.10.2 VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview
- 6.10.3 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio
- 6.10.5 VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Developments
- 6.11 Shenzhen Beike Bio-Technology Co.,Ltd
- 6.11.1 Shenzhen Beike Bio-Technology Co.,Ltd Company Information
- 6.11.2 Shenzhen Beike Bio-Technology Co.,Ltd Business Overview
- 6.11.3 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio
- 6.11.5 Shenzhen Beike Bio-Technology Co.,Ltd Recent Developments
- 6.12 Beijing Health and Biotech Group Corp. Ltd.
- 6.12.1 Beijing Health and Biotech Group Corp. Ltd. Company Information
- 6.12.2 Beijing Health and Biotech Group Corp. Ltd. Business Overview
- 6.12.3 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio
- 6.12.5 Beijing Health and Biotech Group Corp. Ltd. Recent Developments
- 6.13 Shanghai Cell Therapy Group Co. Ltd.
- 6.13.1 Shanghai Cell Therapy Group Co. Ltd. Company Information
- 6.13.2 Shanghai Cell Therapy Group Co. Ltd. Business Overview
- 6.13.3 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio
- 6.13.5 Shanghai Cell Therapy Group Co. Ltd. Recent Developments
- 6.14 BGI Genomics
- 6.14.1 BGI Genomics Company Information
- 6.14.2 BGI Genomics Business Overview
- 6.14.3 BGI Genomics Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 BGI Genomics Autologous Immune Cell Storage Product Portfolio
- 6.14.5 BGI Genomics Recent Developments
- 6.15 Shanghai Saiyao Biotechnology Co., Ltd.
- 6.15.1 Shanghai Saiyao Biotechnology Co., Ltd. Company Information
- 6.15.2 Shanghai Saiyao Biotechnology Co., Ltd. Business Overview
- 6.15.3 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio
- 6.15.5 Shanghai Saiyao Biotechnology Co., Ltd. Recent Developments
- 6.16 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
- 6.16.1 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information
- 6.16.2 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview
- 6.16.3 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio
- 6.16.5 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Developments
7 North America
- 7.1 North America Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 7.3 North America Autologous Immune Cell Storage Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 8.3 Europe Autologous Immune Cell Storage Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Autologous Immune Cell Storage Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 10.3 South America Autologous Immune Cell Storage Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Autologous Immune Cell Storage Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst